Mark L. Berch

Array ( [id] => 5936951 [patent_doc_number] => 20020062023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Active compound from a sponge' [patent_app_type] => new [patent_app_number] => 09/928288 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1684 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20020062023.pdf [firstpage_image] =>[orig_patent_app_number] => 09928288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005459 [patent_doc_number] => 06906055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Phosphonocephem compound' [patent_app_type] => utility [patent_app_number] => 10/343285 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17636 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906055.pdf [firstpage_image] =>[orig_patent_app_number] => 10343285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6624613 [patent_doc_number] => 20020016329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => '2-Amino-6-anilino-purines and their use as medicaments' [patent_app_type] => new [patent_app_number] => 09/927322 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25288 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016329.pdf [firstpage_image] =>[orig_patent_app_number] => 09927322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1327848 [patent_doc_number] => 06599893 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-29 [patent_title] => 'Cephalosporin antibiotics and prodrugs thereof' [patent_app_type] => B2 [patent_app_number] => 09/925217 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9674 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/599/06599893.pdf [firstpage_image] =>[orig_patent_app_number] => 09925217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053396 [patent_doc_number] => 06858727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Intermediate of carbapenem antibiotics and process for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/344267 [patent_app_country] => US [patent_app_date] => 2001-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7014 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858727.pdf [firstpage_image] =>[orig_patent_app_number] => 10344267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875107 [patent_doc_number] => 20020049315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Crystalline forms of carbapenem intermediates' [patent_app_type] => new [patent_app_number] => 09/921221 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1643 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049315.pdf [firstpage_image] =>[orig_patent_app_number] => 09921221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6362874 [patent_doc_number] => 20020058806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'Novel process' [patent_app_type] => new [patent_app_number] => 09/918152 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7844 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058806.pdf [firstpage_image] =>[orig_patent_app_number] => 09918152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6409900 [patent_doc_number] => 20020038024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof' [patent_app_type] => new [patent_app_number] => 09/916099 [patent_app_country] => US [patent_app_date] => 2001-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18972 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20020038024.pdf [firstpage_image] =>[orig_patent_app_number] => 09916099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 702242 [patent_doc_number] => 07064198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-20 [patent_title] => 'Method for preparation of cefuroxime axetil' [patent_app_type] => utility [patent_app_number] => 10/468584 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8007 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/064/07064198.pdf [firstpage_image] =>[orig_patent_app_number] => 10468584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847500 [patent_doc_number] => 20030166667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient' [patent_app_type] => new [patent_app_number] => 10/343453 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7807 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166667.pdf [firstpage_image] =>[orig_patent_app_number] => 10343453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432552 [patent_doc_number] => 20040162277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Anhydrous crystal of beta-lactam compound and method for preparation thereof' [patent_app_type] => new [patent_app_number] => 10/476221 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2776 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162277.pdf [firstpage_image] =>[orig_patent_app_number] => 10476221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1120427 [patent_doc_number] => 06797823 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-28 [patent_title] => 'Quinoline derivatives and quinazoline derivatives' [patent_app_type] => B1 [patent_app_number] => 09/889858 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64432 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/797/06797823.pdf [firstpage_image] =>[orig_patent_app_number] => 09889858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822184 [patent_doc_number] => 20030220345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => '2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimdin-7-ones' [patent_app_type] => new [patent_app_number] => 10/343847 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11130 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220345.pdf [firstpage_image] =>[orig_patent_app_number] => 10343847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7401674 [patent_doc_number] => 20040019057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Imidazo-pyrazine derivatives as ligands for gaba receptors' [patent_app_type] => new [patent_app_number] => 10/333964 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7392 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019057.pdf [firstpage_image] =>[orig_patent_app_number] => 10333964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1083151 [patent_doc_number] => 06833452 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-21 [patent_title] => 'Process for the preparation of highly pure crystalline (R,S)cefuroxime axetil' [patent_app_type] => B2 [patent_app_number] => 09/906256 [patent_app_country] => US [patent_app_date] => 2001-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1810 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/833/06833452.pdf [firstpage_image] =>[orig_patent_app_number] => 09906256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278639 [patent_doc_number] => 06645951 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Benzopyran or thiobenzopyran derivatives' [patent_app_type] => B1 [patent_app_number] => 09/719608 [patent_app_country] => US [patent_app_date] => 2001-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 114589 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645951.pdf [firstpage_image] =>[orig_patent_app_number] => 09719608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6344165 [patent_doc_number] => 20020035117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Theophylline and 3-isobutyl-1-methylxanthine based N-7 substituted derivatives displaying inhibitory activities on type five phosphodiesterase' [patent_app_type] => new [patent_app_number] => 09/906245 [patent_app_country] => US [patent_app_date] => 2001-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6181 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035117.pdf [firstpage_image] =>[orig_patent_app_number] => 09906245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874791 [patent_doc_number] => 20020049208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Imidazo[1,2-a]pyrazines for the treatment of neurological disorders' [patent_app_type] => new [patent_app_number] => 09/905097 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10255 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049208.pdf [firstpage_image] =>[orig_patent_app_number] => 09905097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770475 [patent_doc_number] => 20030216415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones' [patent_app_type] => new [patent_app_number] => 10/343805 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5013 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216415.pdf [firstpage_image] =>[orig_patent_app_number] => 10343805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1387472 [patent_doc_number] => 06552192 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof' [patent_app_type] => B1 [patent_app_number] => 09/889176 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16676 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 2168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552192.pdf [firstpage_image] =>[orig_patent_app_number] => 09889176 [rel_patent_id] =>[rel_patent_doc_number] =>)